Hair loss drug shows long-term sexual side effects

Hair loss drug shows long-term sexual side effects
For men with finasteride-associated side effects, sexual dysfunction may persist for months or years, even after discontinuation of the drug, according to a study published online July 12 in The Journal of Sexual Medicine.

(HealthDay) -- For men with finasteride-associated side effects, sexual dysfunction may persist for months or years, even after discontinuation of the drug, according to a study published online July 12 in The Journal of Sexual Medicine.

Michael S. Irwig, M.D., of George Washington University in Washington, D.C., conducted a prospective study involving 54 young men (mean age, 26 years) with persistent -associated side effects to examine whether the persistent sexual side effects resolve or endure over time. The Arizona Scale (ASEX) was used to measure sexual dysfunction.

The author noted a participation rate of 81 percent. At reassessment (mean 14 months), persistent side effects were still present in 96 percent of participants, and 89 percent met the definition for sexual dysfunction according to the ASEX criteria. Changes in the scores of sexual dysfunction were not affected by the length of finasteride use or the duration of the sexual side effects.

"Men who developed persistent sexual and other side effects lasting for at least three months after discontinuing finasteride continue to have a high prevalence of for subsequent months or years," the author writes. "It is recommended that prescribers of finasteride, as well as potential users, be aware of the potential serious long-term risks of a medication used for a cosmetic purpose."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Baldness drug may cause sexual side effects: FDA

Apr 12, 2012

(HealthDay) -- Two Merck & Co. drugs -- one to treat hair loss in men, the other to treat an enlarged prostate gland -- will get revised labels warning of potential sexual side effects that can last even after ...

Men experience sexual dysfunction during hepatitis C therapy

Sep 01, 2009

Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Instit ...

Recommended for you

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments